ENDOCHOICE HLDGS INC (GI)

[mick]

http://www.otcmarkets.com/stock/GI

[mick]

http://www.stockscores.com/charts/charts/?ticker=GI

[mick]

http://www.barchart.com/detailedquote/stocks/GI

[mick]

Gem International Re (GI)
0.02 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
0.015 0.02 - - -
GI Detailed Quote

[mick]

http://www.barchart.com/opinions/stocks/GI

[mick]

https://www.stockscores.com/charts/charts/?ticker=GI

[mick]

Gem International Re (GI)
0.015 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
0.01 0.015 - - -
GI Detailed Quote

[mick]

Gem International Re (GI)
0.02 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
0.02 0.025 - - -
GI Detailed Quote

[mick]

GI News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 09:01:46 AM
GI News: Amended Statement of Ownership (sc 13g/a) 02/10/2017 04:15:15 PM
GI News: Amended Statement of Ownership (sc 13g/a) 02/02/2017 03:53:21 PM
GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 12/21/2016 11:02:42 AM
GI News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 12/05/2016 12:18:55 PM

[mick]

Gem International Re (GI)
0.035 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
0.035 0.04 - - -
GI Detailed Quote

[mick]

Gem International Re (GI)
0.06 ? -0.005 (-7.69%)
Volume: 275,300 @ 3:41:29 PM ET
Bid Ask Day's Range
0.05 0.06 0.055 - 0.06
GI Detailed Quote

[mick]

GI News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 09:01:46 AM
GI News: Amended Statement of Ownership (sc 13g/a) 02/10/2017 04:15:15 PM
GI News: Amended Statement of Ownership (sc 13g/a) 02/02/2017 03:53:21 PM
GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 12/21/2016 11:02:42 AM
GI News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 12/05/2016 12:18:55 PM

[mick]

Gem International Re (GI)
0.09 ? 0.0 (0.00%)
Volume: 5,000 @ 9:30:00 AM ET
Bid Ask Day's Range
0.085 0.09 0.09 - 0.09
GI Detailed Quote

[mick]

GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 12/21/2016 11:02:42 AM
GI News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 12/05/2016 12:18:55 PM
GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/28/2016 03:44:49 PM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM

[mick]

Endochoice Holdings, (GI)
8.0 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
- - - - -
GI Detailed Quote

[mick]

Endochoice Holdings, (GI)
8.0 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
- - - - -
GI Detailed Quote

[mick]

GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 12/21/2016 11:02:42 AM
GI News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 12/05/2016 12:18:55 PM
GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/28/2016 03:44:49 PM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM

[mick]

Endochoice Holdings, (GI)
8.0 ? 0.0 (0.00%)
Volume: 0 @- ET
Bid Ask Day's Range
- - - - -
GI Detailed Quote

[mick]

GI News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 12/05/2016 12:18:55 PM
GI News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/28/2016 03:44:49 PM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:24:33 AM
GI News: Statement of Changes in Beneficial Ownership (4) 11/23/2016 10:23:41 AM

[mick]

GI News: Amended Statement of Ownership: Solicitation (sc 14d9/a) 10/11/2016 05:00:01 PM
GI News: Schedule 13g 10/11/2016 10:37:56 AM
GI News: Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) 10/11/2016 09:10:48 AM
GI News: ENDOCHOICE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of EndoChoice Holdings, Inc. (GI) Over the Pr... 10/07/2016 05:51:00 PM
GI News: Tender Offer Statement by Third Party (sc To-t) 10/07/2016 08:03:21 AM

[mick]

Endochoice Holdings, (GI)
7.97 ? -0.01 (-0.13%)
Volume: 105,679 @ 4:02:03 PM ET
Bid Ask Day's Range
- - 7.97 - 7.98
GI Detailed Quote

[mick]

GI News: Schedule 13g 08/09/2016 09:31:30 AM
GI News: Robbins Arroyo LLP: EndoChoice Holdings, Inc. (GI) Misled Shareholders According to a Recently Filed Class Action 08/08/2016 07:20:00 PM
GI News: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of EndoChoice Holdings, Inc. of Class Action Lawsuit - GI 08/08/2016 12:36:00 PM
GI News: EndoChoice (GI) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of EndoChoice Holdings, Inc... 08/06/2016 07:54:00 PM
GI News: Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo L... 08/05/2016 11:41:00 AM

[mick]

Endochoice Holdings, (GI)
4.3 ? -0.13 (-2.93%)
Volume: 136,284 @ 4:02:03 PM ET
Bid Ask Day's Range
- - 4.19 - 4.43
GI Detailed Quote

[mick]

GI News: Schedule 13g 08/09/2016 09:31:30 AM
GI News: Robbins Arroyo LLP: EndoChoice Holdings, Inc. (GI) Misled Shareholders According to a Recently Filed Class Action 08/08/2016 07:20:00 PM
GI News: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of EndoChoice Holdings, Inc. of Class Action Lawsuit - GI 08/08/2016 12:36:00 PM
GI News: EndoChoice (GI) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of EndoChoice Holdings, Inc... 08/06/2016 07:54:00 PM
GI News: Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo L... 08/05/2016 11:41:00 AM

[mick]

Endochoice Holdings, (GI)
3.89 ? 0.0 (0.00%)
Volume: 36,385 @ 4:02:01 PM ET
Bid Ask Day's Range
- - 3.83 - 3.9
GI Detailed Quote

[mick]

GI News: Schedule 13g 08/09/2016 09:31:30 AM
GI News: Robbins Arroyo LLP: EndoChoice Holdings, Inc. (GI) Misled Shareholders According to a Recently Filed Class Action 08/08/2016 07:20:00 PM
GI News: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of EndoChoice Holdings, Inc. of Class Action Lawsuit - GI 08/08/2016 12:36:00 PM
GI News: EndoChoice (GI) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of EndoChoice Holdings, Inc... 08/06/2016 07:54:00 PM
GI News: Lifshitz & Miller Law Firm Announces Investigation of American Renal Associates Holdings, Inc., CytRx Corporation, El Pollo L... 08/05/2016 11:41:00 AM

[mick]

Endochoice Holdings, (GI)
3.94 ? -0.06 (-1.50%)
Volume: 36,209 @ 4:02:01 PM ET
Bid Ask Day's Range
- - 3.9 - 4.0
GI Detailed Quote

[mick]

GI News: EndoChoice to Report Second Quarter 2016 Financial Results on August 3, 2016 07/27/2016 09:00:00 AM
GI News: Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against EndoChoice Holdings Inc. (GI... 07/25/2016 10:26:00 AM
GI News: SHAREHOLDERS ALERT: Levi & Korsinsky, LLP Notifies Shareholders of EndoChoice Holdings, Inc. of Class Action Lawsuit 07/22/2016 11:31:00 AM
GI News: Strauss Law P.L.L.C. Announces Investigation of EndoChoice Holdings, Inc. (NYSE: GI) 06/27/2016 11:34:00 AM
GI News: EndoChoice® to Present at William Blair & Company's 36th Annual Growth Stock Conference 06/01/2016 09:01:00 AM

[mick]

Endochoice Holdings, (GI)
5.3 ? -0.03 (-0.56%)
Volume: 1,553 @ 12:48:06 PM ET
Bid Ask Day's Range
- - 5.23 - 5.32
GI Detailed Quote

[mick]

http://www.barchart.com/snapopinion/stocks/gi

[mick]

Jun 1, 2016 09:03 AMEndoChoice® to Present at William Blair & Company's 36th Annual Growth Stock Conference May 23, 2016 12:48 PMEndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves May 19, 2016 05:59 PMEndoChoice® Launches Third Generation Fuse® Full Spectrum Endoscopy® System May 19, 2016 10:59 AMEndoChoice® Launches RescueNet™ Retrieval Device

[mick]

GI News: EndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves 05/23/2016 12:47:00 PM
GI News: EndoChoice® Launches Third Generation Fuse® Full Spectrum Endoscopy® System 05/19/2016 05:59:00 PM
GI News: EndoChoice® Launches RescueNet™ Retrieval Device 05/19/2016 10:58:00 AM
GI News: Securities Registration: Employee Benefit Plan (s-8) 05/05/2016 11:43:08 AM
GI News: Current Report Filing (8-k) 05/04/2016 05:34:15 PM

[mick]

Endochoice Holdings, (GI)
4.34 ? 0.08 (1.88%)
Volume: 41,447 @ 4:36:53 PM ET
Bid Ask Day's Range
- - 4.3 - 4.415
GI Detailed Quote

[mick]

lot of upside on this one/ Endochoice Holdings, (GI)
4.33 ? 0.07 (1.64%)
Volume: 32,691 @ 2:58:59 PM ET
Bid Ask Day's Range
- - 4.3 - 4.415
GI Detailed Quote

[$Pistol Pete$]

$GI Daily Chart

[mick]

http://www.barchart.com/cheatsheet.php?sym=GI

[$Pistol Pete$]

$GI http://www.reuters.com/article/idUSFWN18G0MY

[mick]

unlimited potential here/ the safety for all/ ENDOCHOICE HLDGS INC (GI)'

[mick]

[-chart]finviz.com/chart.ashx?t=GI&ty=c&ta=1&p=d&s=l[/chart]

[mick]

in betweeners/ watching inventor stuff/ 'ENDOCHOICE HLDGS INC (GI)'

[mick]

doing ah lot reads/

[$Pistol Pete$]

Agreed and I bought them at $4.37

[mick]

you are welcome. these readings are huge. was $16 'ENDOCHOICE HLDGS INC (GI)'

[mick]

EndoChoice® Launches RescueNet™ Retrieval Device
Date : 05/19/2016 @ 10:58AM
Source : PR Newswire (US)
Stock : Endochoice Holdings, Inc. (GI)
Quote : 4.27 -0.24 (-5.32%) @ 2:27PM
EndoChoice® Launches RescueNet™ Retrieval Device

http://ih.advfn.com/p.php?pid=nmona&article=71529057

ALPHARETTA, Ga., May 19, 2016 /PRNewswire/
-- EndoChoice Holdings, Inc. (NYSE: GI) announced the full market release of its RescueNet™ retrieval device.
Based upon the OmniLoop™ technology unveiled with the Boa® polypectomy snare,
RescueNet's design also incorporates new ProMesh™ technology. RescueNet™ provides greater visibility and control with improved mesh strength,
which allows for reliable and efficient foreign body removal.
The company is beginning sales and distribution in the United States, European Union, and other select markets.

Since its recent introduction, RescueNet™ has been extremely well received by nurses and physicians.
"The RescueNet is the best on the market today.
It opens and closes in any position, adjustable, and works time after time. It never seems to wear out,"
stated Jerry Rayfield, GI Nurse Manager at Russell Medical Center, Alexander City, AL.

This year EndoChoice will be highlighting RescueNet™ in its booth
at Digestive Disease Week (DDW®) in San Diego, California, and at
the SGNA 43rd Annual Course in Seattle, Washington.

Commenting on the new product release, Mark Gilreath,
Founder and CEO of EndoChoice said
"This innovation is the result of
our company's unique insights into the needs of GI caregivers to
provide tools which improve the efficiency and effectiveness of
their clinical procedures.

RescueNet™ is the perfect addition to our family of Rescue® retrieval devices and the EndoChoice® portfolio of polypectomy devices, which includes the Boa® polypectomy snare, Mako™ biopsy forceps, Neptune® injection needle, and the TrapEase® polyp trap."

About DDW

Digestive Disease Week® (DDW) is the largest international gathering
of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD),
the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the
Society for Surgery of the Alimentary Tract (SSAT),
DDW take place May 21-24, 2016, at the San Diego Convention Center,
San Diego, CA.

The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology.
More information can be found at http://www.ddw.org

About SGNA

The Society of Gastroenterology Nurses and Associates, Inc. (SGNA™) 43rd Annual Course in Seattle is
the premier education and networking event dedicated to
gastroenterology and endoscopy nursing professionals.

The event will take place May 22-24, 2016 in Seattle, Washington. More information can be found at http://www.sgna.org/2016annualcourse

About EndoChoice

Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech
company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer.

EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries.

The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For more information, press only:

Company Contact:

Ryan Moskowitz
Senior Director, Marketing Communications
EndoChoice
678-708-4403
[e-mail]

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[e-mail]
[e-mail]

Photo -
http://photos.prnewswire.com/prnh/20160519/369814

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endochoice-launches-rescuenet-retrieval-device-300271735.html

SOURCE EndoChoice


Copyright 2016 PR Newswire

[mick]

EndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves
Date : 05/23/2016 @ 12:47PM
Source : PR Newswire (US)
Stock : Endochoice Holdings, Inc. (GI)
Quote : 4.2684 -0.2416 (-5.36%) @ 2:21PM
EndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves

http://ih.advfn.com/p.php?pid=nmona&article=71552024

ALPHARETTA, Ga., May 23, 2016 /PRNewswire/
-- EndoChoice Holdings, Inc. (NYSE: GI) announced it received 510(k) clearance for its new Orca™ sterile,
single-use air/water and suction valves for Olympus® 160, 180 and 190 Series flexible endoscopes.

Recently published clinical guidelines from Association for the Advancement of Medical Instrumentation (AAMI) and the Society of Gastroenterology Nurses and Associates (SGNA),
state that reusable endoscopic accessories (e.g., air/water and
suction valves) should be reprocessed together and stored with a specific endoscope as a unique set to ensure traceability.

By eliminating the need to clean and disinfect reusable valves,
the single use Orca™ valves allow clinicians to adhere to these new guidelines while improving patient care and workflow efficiency.

The company will begin sales and distribution of the new valves in the United States,
European Union, and other select markets.

EndoChoice will highlight the new sterile, single-use valves at Digestive Disease Week® (DDW®) in San Diego,
California (Booth #4317), and at the SGNA™ 43rd Annual Course in Seattle, Washington.

EndoChoice will display at these meetings May 22 to 24.

Commenting on the announcement, Mark Gilreath, Founder and CEO of EndoChoice said,
"EndoChoice has been dedicated to improving the standard of care
for infection control since 2010, when it launched the Compliance EndoKit®, the first GI procedural kit designed to help clinicians standardize to good infection control practices.

The Orca™ sterile single use air/water and suction valves are an excellent addition to the Compliance EndoKit®, thus continuing to improve the standard of care in GI."

About EndoChoice

Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer.

EndoChoice leverages its direct sales organization to serve more
than 2,500 customers in the United States and works with distribution partners in 30 countries.

The Company was founded in 2008 and has rapidly developed a broad
and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system.
EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For more information, press only:

Company Contact:

Ryan Moskowitz
Senior Director, Marketing Communications
EndoChoice
678-708-4403
[e-mail]

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[e-mail]
[e-mail]

To view the original version on PR Newswire, visit:
http://www.prnewswire.com/news-releases/endochoice-announces-fda-clearance-of-its-orca-sterile-single-use-airwater-and-suction-valves-300273174.html

SOURCE EndoChoice


Copyright 2016 PR Newswire

[mick]

EndoChoice® Launches Third Generation Fuse® Full Spectrum Endoscopy® System
Date : 05/19/2016 @ 5:59PM
Source : PR Newswire (US)
Stock : Endochoice Holdings, Inc. (GI)
Quote : 4.26 -0.25 (-5.54%) @ 2:18PM
EndoChoice® Launches Third Generation Fuse® Full Spectrum Endoscopy® System

http://ih.advfn.com/p.php?pid=nmona&article=71532978

ALPHARETTA, Ga., May 19, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today the full market release of its Generation 3 Full Spectrum Endoscopy® (Fuse®) system. Fuse Generation 3 includes an ergonomically advanced control body, incorporating over 50 system enhancements and a novel Adaptive Matrix Imaging technology called Lumos™, that enables physicians to see more with enhanced clarity. The company is beginning sales and distribution of Generation 3 scopes in the United States, European Union, and other select markets.

Lumos Adaptive Matrix Imaging takes a revolutionary approach to enhance the view of the mucosal structures and vascular patterns in their natural color and the ability for "always-on" functionality via smart enhancement technology, making it the first advanced imaging solution designed to improve the entire procedure. Lumos is now launched in Europe with the CE mark, and is pending FDA clearance in the United States.

EndoChoice will highlight Fuse Generation 3 at Digestive Disease Week® (DDW®) in San Diego, California (Booth #4317), and at the SGNA™ 43rd Annual Course in Seattle, Washington. EndoChoice will display at these meetings May 22 to 24.

Commenting on the new product release, Dr. Booker Dalton, Gastroenterologist at Digestive Healthcare of Georgia, said "Fuse Generation 3 is a significant advancement of the Full Spectrum Endoscopy system. Fuse's new ergonomic design and system refinements greatly enhance the overall user experience. Coupled with its already impressive 330-degree field of view and published clinical value, Fuse is a game changer."

Mark Gilreath, Founder and CEO of EndoChoice, stated, "We are truly excited to bring Fuse Generation 3 and Lumos to the world of GI. With Generation 3, not only do GI's have an increased field of view to help detect lesions, they now have the ability to enhance anatomy like never before with Lumos Adaptive Matrix Imaging. We believe these advancements take the Fuse platform to an unprecedented level in endoscopic screening."

About DDW

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW take place May 21-24, 2016, at the San Diego Convention Center, San Diego, CA. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at http://www.ddw.org

About SGNA

The Society of Gastroenterology Nurses and Associates, Inc. (SGNA™) 43rd Annual Course in Seattle is the premier education and networking event dedicated to gastroenterology and endoscopy nursing professionals. The event will take place May 22-24, 2016 in Seattle, Washington. More information can be found at HTTP://www.sgna.org/2016annualcourse

About EndoChoice

Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer.

EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For more information, press only:

Company Contact:

David Gill, President & CFO
678-585-1040
[e-mail]

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[e-mail]
[e-mail]

Photo - http://photos.prnewswire.com/prnh/20160519/370112

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endochoice-launches-third-generation-fuse-full-spectrum-endoscopy-system-300272072.html

SOURCE EndoChoice


Copyright 2016 PR Newswire

[$Pistol Pete$]

I bought 5000 shares

Go $GI

[$Pistol Pete$]

Thanks for your DD

Go $GI

[$Pistol Pete$]

$GI EndoChoice® Announces FDA Clearance of its Orca™ Sterile, Single-Use Air/Water and Suction Valves

Source: PR Newswire (US)
ALPHARETTA, Ga., May 23, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced it received 510(k) clearance for its new Orca™ sterile, single-use air/water and suction valves for Olympus® 160, 180 and 190 Series flexible endoscopes. Recently published clinical guidelines from Association for the Advancement of Medical Instrumentation (AAMI) and the Society of Gastroenterology Nurses and Associates (SGNA), state that reusable endoscopic accessories (e.g., air/water and suction valves) should be reprocessed together and stored with a specific endoscope as a unique set to ensure traceability. By eliminating the need to clean and disinfect reusable valves, the single use Orca™ valves allow clinicians to adhere to these new guidelines while improving patient care and workflow efficiency. The company will begin sales and distribution of the new valves in the United States, European Union, and other select markets.

EndoChoice will highlight the new sterile, single-use valves at Digestive Disease Week® (DDW®) in San Diego, California (Booth #4317), and at the SGNA™ 43rd Annual Course in Seattle, Washington. EndoChoice will display at these meetings May 22 to 24.

Commenting on the announcement, Mark Gilreath, Founder and CEO of EndoChoice said, "EndoChoice has been dedicated to improving the standard of care for infection control since 2010, when it launched the Compliance EndoKit®, the first GI procedural kit designed to help clinicians standardize to good infection control practices. The Orca™ sterile single use air/water and suction valves are an excellent addition to the Compliance EndoKit®, thus continuing to improve the standard of care in GI."

About EndoChoice

Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For more information, press only:

Company Contact:

Ryan Moskowitz
Senior Director, Marketing Communications
EndoChoice
678-708-4403
[e-mail]

Investor Contacts:

Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[e-mail]
[e-mail]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endochoice-announces-fda-clearance-of-its-orca-sterile-single-use-airwater-and-suction-valves-300273174.html

SOURCE EndoChoice


Copyright 2016 PR Newswire

[$Pistol Pete$]

$GI 15' Chart